{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:33:33Z","timestamp":1783402413389,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773764"],"award-info":[{"award-number":["81773764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073875"],"award-info":[{"award-number":["82073875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073865"],"award-info":[{"award-number":["82073865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"the Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["29201731121100101"],"award-info":[{"award-number":["29201731121100101"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["XDA12020104"],"award-info":[{"award-number":["XDA12020104"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["XDA12020109"],"award-info":[{"award-number":["XDA12020109"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"the Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["CASIMM0120185003"],"award-info":[{"award-number":["CASIMM0120185003"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19QA1410900"],"award-info":[{"award-number":["19QA1410900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10637-021-01096-4","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T05:02:32Z","timestamp":1615525352000},"page":"1213-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-9449","authenticated-orcid":false,"given":"Meng-Zhu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Bin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Kang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Hong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"issue":"3\u20134","key":"1096_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10555-013-9429-5","volume":"32","author":"L Pikor","year":"2013","unstructured":"Pikor L, Thu K, Vucic E, Lam W (2013) The detection and implication of genome instability in cancer. Cancer Metastasis Rev 32(3\u20134):341\u2013352","journal-title":"Cancer Metastasis Rev"},{"key":"1096_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fonc.2019.00395","volume":"9","author":"LM do Canto","year":"2019","unstructured":"do Canto LM, Larsen SJ, Catin Kupper BE, Begnami M, Scapulatempo-Neto C, Petersen AH, Aagaard MM, Baumbach J, Aguiar S Jr, Rogatto SR (2019) Increased levels of genomic instability and mutations in homologous recombination genes in locally advanced rectal carcinomas. Front Oncol 9:395","journal-title":"Front Oncol"},{"issue":"10","key":"1096_CR3","doi-asserted-by":"publisher","first-page":"T19","DOI":"10.1530\/ERC-16-0221","volume":"23","author":"Y Katsuki","year":"2016","unstructured":"Katsuki Y, Takata M (2016) Defects in homologous recombination repair behind the human diseases: FA and HBOC. Endocr Relat Cancer 23(10):T19\u2013T37","journal-title":"Endocr Relat Cancer"},{"issue":"21","key":"1096_CR4","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1021\/acs.jmedchem.6b00055","volume":"59","author":"YQ Wang","year":"2016","unstructured":"Wang YQ, Wang PY, Wang YT, Yang GF, Zhang A, Miao ZH (2016) An update on poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors: opportunities and challenges in cancer therapy. J Med Chem 59(21):9575\u20139598","journal-title":"J Med Chem"},{"key":"1096_CR5","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.2147\/CMAR.S227033","volume":"12","author":"E Nizialek","year":"2020","unstructured":"Nizialek E, Antonarakis ES (2020) PARP inhibitors in metastatic prostate cancer: evidence to date. Cancer Manag Res 12:8105\u20138114","journal-title":"Cancer Manag Res"},{"key":"1096_CR6","doi-asserted-by":"publisher","unstructured":"Ter Brugge P, Kristel P, van der Burg E, Boon U, de Maaker M, Lips E, Mulder L, de Ruiter J, Moutinho C, Gevensleben H, Marangoni E, Majewski I, Jozwiak K, Kloosterman W, van Roosmalen M, Duran K, Hogervorst F, Turner N, Esteller M, Cuppen E, Wesseling J, Jonkers J (2016) Mechanisms of therapy resistance in patient-derived xenograft models of BRCA1-deficient breast cancer. J Natl Cancer Inst 108(11). https:\/\/doi.org\/10.1093\/jnci\/djw148","DOI":"10.1093\/jnci\/djw148"},{"issue":"29","key":"1096_CR7","doi-asserted-by":"publisher","first-page":"47154","DOI":"10.18632\/oncotarget.17005","volume":"8","author":"S Rafii","year":"2017","unstructured":"Rafii S, Gourley C, Kumar R, Geuna E, Ern Ang J, Rye T, Chen LM, Shapira-Frommer R, Friedlander M, Matulonis U, De Greve J, Oza AM, Banerjee S, Molife LR, Gore ME, Kaye SB, Yap TA (2017) Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1\/2 mutated patients with advanced ovarian cancer. Oncotarget 8(29):47154\u201347160","journal-title":"Oncotarget"},{"issue":"11","key":"1096_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tig.2016.09.004","volume":"32","author":"AL Valton","year":"2016","unstructured":"Valton AL, Prioleau MN (2016) G-quadruplexes in DNA replication: a problem or a necessity? Trends Genet 32(11):697\u2013706","journal-title":"Trends Genet"},{"issue":"8","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41580-020-0236-x","volume":"21","author":"D Varshney","year":"2020","unstructured":"Varshney D, Spiegel J, Zyner K, Tannahill D, Balasubramanian S (2020) The regulation and functions of DNA and RNA G-quadruplexes. Nat Rev Mol Cell Biol 21(8):459\u2013474","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1096_CR10","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1038\/ncomms14432","volume":"8","author":"H Xu","year":"2017","unstructured":"Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O\u2019Neil NJ, Santos ND, Silvester J, Wei V, Garcia J, Kabeer F, Lai D, Soriano P, Banath J, Chiu DS, Yap D, Le DD, Ye FB, Zhang A, Thu K, Soong J, Lin SC, Tsai AH, Osako T, Algara T, Saunders DN, Wong J, Xian J, Bally MB, Brenton JD, Brown GW, Shah SP, Cescon D, Mak TW, Caldas C, Stirling PC, Hieter P, Balasubramanian S, Aparicio S (2017) CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours. Nat Commun 8:14432","journal-title":"Nat Commun"},{"issue":"3","key":"1096_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2015.12.004","volume":"61","author":"J Zimmer","year":"2016","unstructured":"Zimmer J, Tacconi EMC, Folio C, Badie S, Porru M, Klare K, Tumiati M, Markkanen E, Halder S, Ryan A, Jackson SP, Ramadan K, Kuznetsov SG, Biroccio A, Sale JE, Tarsounas M (2016) Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds. Mol Cell 61(3):449\u2013460","journal-title":"Mol Cell"},{"issue":"1","key":"1096_CR12","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","volume":"11","author":"E Sanij","year":"2020","unstructured":"Sanij E, Hannan KM, Xuan J, Yan S, Ahern JE, Trigos AS, Brajanovski N, Son J, Chan KT, Kondrashova O, Lieschke E, Wakefield MJ, Frank D, Ellis S, Cullinane C, Kang J, Poortinga G, Nag P, Deans AJ, Khanna KK, Mileshkin L, McArthur GA, Soong J, Berns E, Hannan RD, Scott CL, Sheppard KE, Pearson RB (2020) CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer. Nat Commun 11(1):2641","journal-title":"Nat Commun"},{"issue":"1","key":"1096_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","volume":"22","author":"MJ Bywater","year":"2012","unstructured":"Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, Wall M, Cluse L, Drygin D, Anderes K, Huser N, Proffitt C, Bliesath J, Haddach M, Schwaebe MK, Ryckman DM, Rice WG, Schmitt C, Lowe SW, Johnstone RW, Pearson RB, McArthur GA, Hannan RD (2012) Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 22(1):51\u201365","journal-title":"Cancer Cell"},{"issue":"21","key":"1096_CR14","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","volume":"129","author":"N Hein","year":"2017","unstructured":"Hein N, Cameron DP, Hannan KM, Nguyen NN, Fong CY, Sornkom J, Wall M, Pavy M, Cullinane C, Diesch J, Devlin JR, George AJ, Sanij E, Quin J, Poortinga G, Verbrugge I, Baker A, Drygin D, Harrison SJ, Rozario JD, Powell JA, Pitson SM, Zuber J, Johnstone RW, Dawson MA, Guthridge MA, Wei A, McArthur GA, Pearson RB, Hannan RD (2017) Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood 129(21):2882\u20132895","journal-title":"Blood"},{"issue":"8","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","volume":"9","author":"A Khot","year":"2019","unstructured":"Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, Lim J, Soong J, Link E, Blombery P, Thompson ER, Fellowes A, Sheppard KE, McArthur GA, Pearson RB, Hannan RD, Poortinga G, Harrison SJ (2019) First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study. Cancer Discov 9(8):1036\u20131049","journal-title":"Cancer Discov"},{"issue":"19","key":"1096_CR16","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3390\/molecules24193439","volume":"24","author":"TM Bryan","year":"2019","unstructured":"Bryan TM (2019) Mechanisms of DNA replication and repair: insights from the study of G-quadruplexes. Molecules 24(19):3439","journal-title":"Molecules"},{"issue":"2","key":"1096_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/cells9020266","volume":"9","author":"R Ferreira","year":"2020","unstructured":"Ferreira R, Schneekloth JS Jr, Panov KI, Hannan KM, Hannan RD (2020) Targeting the RNA polymerase I transcription for cancer therapy comes of age. Cells 9(2):266","journal-title":"Cells"},{"issue":"9","key":"1096_CR18","first-page":"2813","volume":"10","author":"HD Chen","year":"2020","unstructured":"Chen HD, Guo N, Song SS, Chen CH, Miao ZH, He JX (2020) Novel mutations in BRCA2 intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors. Am J Cancer Res 10(9):2813\u20132831","journal-title":"Am J Cancer Res"},{"key":"1096_CR19","doi-asserted-by":"crossref","unstructured":"Mergny JL, Lacroix L (2009) Uv melting of g-quadruplexes. Curr Protoc Nucleic Acid Chem Chap. 17:17.1.1-17.1.15","DOI":"10.1002\/0471142700.nc1701s37"},{"issue":"2","key":"1096_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.celrep.2018.03.066","volume":"23","author":"T Wei","year":"2018","unstructured":"Wei T, Najmi SM, Liu H, Peltonen K, Kucerova A, Schneider DA, Laiho M (2018) Small-molecule targeting of RNA polymerase I activates a conserved transcription elongation checkpoint. Cell Rep 23(2):404\u2013414","journal-title":"Cell Rep"},{"key":"1096_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2016.11.010","volume":"386","author":"B Yuan","year":"2017","unstructured":"Yuan B, Ye N, Song SS, Wang YT, Song Z, Chen HD, Chen CH, Huan XJ, Wang YQ, Su Y, Shen YY, Sun YM, Yang XY, Chen Y, Guo SY, Gan Y, Gao ZW, Chen XY, Ding J, He JX, Zhang A, Miao ZH (2017) Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. Cancer Lett 386:47\u201356","journal-title":"Cancer Lett"},{"issue":"3","key":"1096_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/cas.13477","volume":"109","author":"YT Wang","year":"2018","unstructured":"Wang YT, Yuan B, Chen HD, Xu L, Tian YN, Zhang A, He JX, Miao ZH (2018) Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression. Cancer Sci 109(3):821\u2013831","journal-title":"Cancer Sci"},{"issue":"3","key":"1096_CR23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ijc.32131","volume":"145","author":"HD Chen","year":"2019","unstructured":"Chen HD, Chen CH, Wang YT, Guo N, Tian YN, Huan XJ, Song SS, He JX, Miao ZH (2019) Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor\u2019s cytotoxicity. Int J Cancer 145(3):714\u2013727","journal-title":"Int J Cancer"},{"issue":"3","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.18632\/oncotarget.13749","volume":"8","author":"JX He","year":"2017","unstructured":"He JX, Wang M, Huan XJ, Chen CH, Song SS, Wang YQ, Liao XM, Tan C, He Q, Tong LJ, Wang YT, Li XH, Su Y, Shen YY, Sun YM, Yang XY, Chen Y, Gao ZW, Chen XY, Xiong B, Lu XL, Ding J, Yang CH, Miao ZH (2017) Novel PARP1\/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution. Oncotarget 8(3):4156\u20134168","journal-title":"Oncotarget"},{"issue":"7","key":"1096_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1021\/ml300110s","volume":"3","author":"M Haddach","year":"2012","unstructured":"Haddach M, Schwaebe MK, Michaux J, Nagasawa J, O\u2019Brien SE, Whitten JP, Pierre F, Kerdoncuff P, Darjania L, Stansfield R, Drygin D, Anderes K, Proffitt C, Bliesath J, Siddiqui-Jain A, Omori M, Huser N, Rice WG, Ryckman DM (2012) Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics. ACS Med Chem Lett 3(7):602\u2013606","journal-title":"ACS Med Chem Lett"},{"issue":"98","key":"1096_CR26","doi-asserted-by":"publisher","first-page":"37080","DOI":"10.18632\/oncotarget.26354","volume":"9","author":"K Sun","year":"2018","unstructured":"Sun K, Mikule K, Wang Z, Poon G, Vaidyanathan A, Smith G, Zhang ZY, Hanke J, Ramaswamy S, Wang J (2018) A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models. Oncotarget 9(98):37080\u201337096","journal-title":"Oncotarget"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-021-01096-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T05:07:58Z","timestamp":1678511278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-021-01096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s10637-021-01096-4","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest were disclosed.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The guidelines of Institutional Animal Care and Use Committee of Shanghai Institute of Materia Medica for the care and use of animals were followed.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}